Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

New Bionic Ear Can Even Pick Up Your Favorite Radio Station

For a while now, the combination of 3-D printing and electronics have allowed researchers to develop custom prosthetics for individuals afflicted with various disabilities. For example, it used to be that one of the treatments for microtia, the underdevelopment of the external ear, required either harvesting a piece of the patient’s rib or using a […]

Read More »

I’m behind on my health insurance premiums. How long will they continue to pay my claims?

This Q&A column addresses questions from real patients about health care costs. Have a question you’d like to see answered? Submit it to AskChristina@nerdwallet.com. Question: I purchased my health insurance through Healthcare.gov last year. I’ve made all of my payments on time, until now. My income was recently cut by about 25% when I lost […]

Read More »

New Bionic Ear Can Even Pick Up Your Favorite Radio Station, Cornell University Study

For a while now, the combination of 3-D printing and electronics have allowed researchers to develop custom prosthetics for individuals afflicted with various disabilities. For example, it used to be that one of the treatments for microtia, the underdevelopment of the external ear, required either harvesting a piece of the patient’s rib or using a […]

Read More »

Google Partners With Broad Institute of MIT and Harvard University to Bring Genome Analysis Tool to its Cloud Platform

CAMBRIDGE, Mass., June 24, 2015 /PRNewswire/ — Broad Institute of MIT and Harvard is teaming up with Google Genomics to explore how to break down major technical barriers that increasingly hinder biomedical research by addressing the need for computing infrastructure to store and process enormous datasets, and by creating tools to analyze such data and unravel […]

Read More »

AbbVie’s Viekira Pak Clears Another Hurdle, 100% HCV-1b Clearance Rate in Phase III Trial

NORTH CHICAGO, Ill., June 24, 2015 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced TURQUOISE-III study results demonstrating 100 percent (n=60/60) sustained virologic response at 12 weeks post-treatment (SVR12) in genotype 1b (GT1b) chronic hepatitis C virus (HCV) infected adult patients with compensated liver cirrhosis.1 Patients received 12 weeks of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir […]

Read More »

Alcobra’s Fragile X Syndrome Drug Fails During Mid-Stage Trial

Israel-based Alcobra Ltd. (ADHD) said its drug treating Fragile X, a genetic disorder that could lead to autism, failed to meet its primary endpoint in a mid-stage trial.   The company’s stock dropped this morning in response to the news. Shares of Alcobra (ADHD) were down about 13 percent, hitting a low of $6.76 per […]

Read More »

AstraZeneca PLC Loses Another Top Exec as Vectura Group plc Gets New CEO

AstraZeneca has lost a second senior executive in a fortnight with the departure of its respiratory and inflammatory medicines head James Ward-Lilley to become chief executive of lung drug specialist Vectura. His departure follows the exit earlier this month of Briggs Morrison, AstraZeneca’s former chief medical officer and head of late-stage drug development, who moved […]

Read More »

Medication May Stop Drug And Alcohol Addiction, University of Texas Study

AUSTIN, Texas — Researchers at The University of Texas at Austin have successfully stopped cocaine and alcohol addiction in experiments using a drug already approved by the U.S. Food and Drug Administration (FDA) to treat high blood pressure. If the treatment is proven effective in humans, it would be the first of its kind — […]

Read More »

Medical Marijuana: Good Evidence For Some Diseases, Weak For Others

Moderate- or high-quality evidence supports the use of marijuana for some medical conditions, but not for others, according to a fresh review of past research. After reviewing 80 randomized trials that included nearly 6,500 people, researchers found moderate support for using marijuana to treat chronic pain and muscle spasms and involuntary movements. The evidence wasn’t […]

Read More »

New Knowledge: Parkinson’s Disease May Begin In The Gut, Aarhus University Study

New Knowledge: Parkinson’s Disease May Begin In The Gu A major epidemiological registry-based study from Aarhus University and Aarhus University Hospital indicates that Parkinson’s disease begins in the gastrointestinal tract. The study is the largest in the field so far. The chronic neurodegenerative Parkinson’s disease affects an increasing number of people. However, scientists still do […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom